Genenta Science SPA (GNTA) FinancialsGNTAGenenta Science SPA

Evaluating the bottom line, Genenta Science SpA maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -60.15%, provide a clear picture of how effectively GNTA converts its operational activities into shareholder value.

In the context of the broader market, GNTA competes directly with industry leaders such as BFRI and CNSY. With a market capitalization of $47.77M, it holds a leading position in the sector. When comparing efficiency, GNTA's gross margin of N/A stands against BFRI's 79.92% and CNSY's 100.00%. Such benchmarking helps identify whether Genenta Science SpA is trading at a premium or discount relative to its financial performance.

The forward P/E ratio is 0, indicating no expected earnings growth, and the price-to-sales ratio is 0, suggesting no revenue generation at this time. The company also has a negative P/E ratio of -3.028, which is concerning for long-term investors.